Real-world improvements in cost, readmissions and in-hospital mortality*
| Condition | Annualised current†volume | Readmissions | In-hospital mortality | Total direct cost | ||||||
| Baseline‡ (%) | Current† (%) | P value | Baseline‡ (%) | Current† (%) | P value | Baseline‡ ($) | Current† ($) | P value | ||
| SVT | 999 | 13.9 | 8.9 | <0.001 | 2.0 | 1.4 | 0.299 | 3917 | 3424 | 0.001 |
| HF | 3114 | 20.0 | 14.9 | <0.001 | 2.8 | 2.5 | 0.529 | 4693 | 4388 | 0.035 |
| CAD (MI) | 954 | 13.7 | 11.3 | 0.112 | 6.8 | 5.5 | 0.254 | 5210 | 5155 | 0.409 |
| VHD | 45 | 15.6 | 16.7 | 0.777 | 4.1 | 4.6 | 0.645 | 6053 | 7404 | 0.730 |
*Baseline rates are adjusted to match disease severity in the pre–post populations.
†Current: September 2017–April 2018.
‡Baseline: September 2015–August 2016.
CAD, coronary artery disease; HF, heart failure; MI, myocardial infarction; SVT, supraventricular tachyarrhythmia; VHD, valvular heart disease.